Novo Nordisk A/S (NVO)
59.61
-0.25
(-0.42%)
USD |
NYSE |
Jan 13, 13:47
Novo Nordisk Market Cap: 264.88B for Jan. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 13.04B |
| Evaxion AS | 31.58M |
| Regeneron Pharmaceuticals, Inc. | 79.41B |
| Omeros Corp. | 864.28M |
| Viking Therapeutics, Inc. | 3.439B |
Market Cap Related Metrics
| PE Ratio | 17.36 |
| PS Ratio | 5.687 |
| PEG Ratio | 1.534 |
| Price to Book Value | 13.07 |
| Price to Free Cash Flow | 28.72 |
| Price | 59.61 |
| Earnings Yield | 5.76% |
| PEGY Ratio | 1.222 |
| Operating PE Ratio | 13.41 |
| Normalized PE Ratio | 17.36 |